bioMérieux Etest Ceftolozane/Tazobactam - Taiwan Registration c57095b56dbae0178e7a79660be91308
Access comprehensive regulatory information for bioMérieux Etest Ceftolozane/Tazobactam in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c57095b56dbae0178e7a79660be91308 and manufactured by bioMérieux SA. The authorized representative in Taiwan is Hong Kong Commercial Mérieux S.p.A. Taiwan Branch.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
c57095b56dbae0178e7a79660be91308
Ministry of Health Medical Device Import No. 031810
DHA05603181001
Product Details
This product is a quantitative detection technique for antibiotic susceptibility, which can be used to determine the minimum inhibitory concentration of gram-negative aerobes (Enterobacter cloacae, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoiae, Proteus mirabilis, Pseudomonas aemginosa) in μg/mL.
C Immunology and microbiology devices
C1640 Antimicrobial susceptibility test powder
Imported from abroad
Dates and Status
Nov 27, 2018
Nov 27, 2023